Students Use Agora to Launch Biotech Start-Up for Alzheimer’s Therapeutic
By Zoë Leanza In May 2020, a group of students from the University of Arizona launched a biotechnology start-up called Cliacept (CLEE-a-cept). Cliacept is working to develop an effective and affordable treatment for Alzheimer’s disease (AD). Cliacept is pursuing a protein called chloride [...]
Resilience AD and Longevity Workshop
Resilience AD and Longevity Workshop | June 28, 2023 The new Exceptional Longevity Data Management and Coordination Center is excited to welcome postdocs, principal investigators, and staff scientists involved in exceptional longevity and/or cognitive resilience research to a virtual [...]
Publications in the News: Overcoming missed connections to battle Alzheimer’s
A recent study using data from the AD Knowledge Portal revealed that a protein important for neuron communication is associated with patient resistance to Alzheimer’s disease and may delay cognitive decline. Read more from Marissa Locke Rottinghaus, science and policy communications specialist for the [...]
MODEL-AD Grant Renewal
The National Institute on Aging (NIA), the largest branch for Alzheimer’s disease research within the National Institutes of Health (NIH), has renewed the Model Organism Development and Evaluation for Late-Onset Alzheimer’s Disease (MODEL-AD) program, awarding a total of $95.8 million over the next five years to [...]